PCLAF and ovarian carcinoma: PAF, the sole ligand of PAFR, is secreted by many different cell types, including endothelial, stromal and inflammatory cells, as well as many different tumor cells [29-31], thus indicating an important role of PAF/PAFR signaling in ovarian cancer progression.